HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shinichi Sato Selected Research

indium-bleomycin

1/2018Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells.
1/2017Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.
2/2016Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune Cells.
2/2015Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice.
1/2015Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis.
6/2014Effects of the immunosuppressant rapamycin on the expression of human α2(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts.
4/2014Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shinichi Sato Research Topics

Disease

143Systemic Scleroderma (Systemic Sclerosis)
11/2022 - 06/2002
57Inflammation (Inflammations)
04/2022 - 03/2002
57Fibrosis (Cirrhosis)
01/2022 - 06/2002
45Neoplasms (Cancer)
11/2022 - 09/2006
36Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 07/2003
29Sclerosis
11/2022 - 06/2002
26Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 10/2008
25Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2022 - 11/2002
21Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2014 - 06/2002
20Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
11/2022 - 12/2011
18Atopic Dermatitis (Atopic Eczema)
09/2022 - 04/2003
16Autoimmune Diseases (Autoimmune Disease)
01/2022 - 10/2005
15Infections
11/2020 - 01/2002
15Urinary Tract Infections (Urinary Tract Infection)
08/2006 - 08/2002
14Hemorrhage
04/2022 - 03/2002
13Contact Dermatitis (Eczema, Contact)
10/2020 - 04/2003
11Dermatitis
09/2022 - 05/2007
11Mycosis Fungoides
11/2021 - 03/2013
11Arthus Reaction
02/2021 - 03/2002
11Dermatomyositis (Dermatopolymyositis)
10/2011 - 04/2003
10Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 10/2008
10Hypertension (High Blood Pressure)
02/2021 - 08/2002
9Edema (Dropsy)
02/2021 - 03/2002
9digital ulcers
11/2020 - 06/2009
9Bullous Pemphigoid (Pemphigoid)
06/2019 - 06/2004
9Coronary Disease (Coronary Heart Disease)
12/2012 - 02/2002
8Melanoma (Melanoma, Malignant)
01/2022 - 12/2005
8Pulmonary Arterial Hypertension
01/2020 - 01/2006
7Localized Scleroderma (Morphea)
08/2020 - 01/2003
7Hypoxia (Hypoxemia)
01/2020 - 04/2010
7Wounds and Injuries (Trauma)
11/2018 - 09/2007
7Ischemic Stroke
11/2014 - 08/2002
7Diffuse Scleroderma (Progressive Systemic Sclerosis)
06/2014 - 04/2003
7Stroke (Strokes)
02/2013 - 08/2002
6Ulcerative Colitis
12/2019 - 10/2006
6Disease Progression
01/2018 - 06/2011
5Pruritus (Itching)
06/2022 - 03/2013
5Cicatrix (Scar)
05/2022 - 06/2004
5Neoplasm Metastasis (Metastasis)
01/2022 - 12/2005
5Telangiectasis (Telangiectasia)
08/2021 - 12/2008
5Vasculitis (Vasculitides)
02/2021 - 06/2009
5Skin Diseases (Skin Disease)
03/2019 - 06/2011
5Connective Tissue Diseases (Connective Tissue Disease)
08/2014 - 10/2005
5Hemorrhagic Stroke
02/2013 - 08/2002
5Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2010 - 06/2007

Drug/Important Bio-Agent (IBA)

42CytokinesIBA
01/2022 - 11/2002
35AutoantibodiesIBA
01/2022 - 06/2002
21Bleomycin (Blenoxane)FDA LinkGeneric
01/2022 - 11/2002
20Proteins (Proteins, Gene)FDA Link
03/2022 - 01/2003
20ChemokinesIBA
01/2022 - 05/2004
19Interleukin-6 (Interleukin 6)IBA
01/2022 - 06/2002
18Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2018 - 03/2002
18EnzymesIBA
05/2018 - 04/2003
18L-SelectinIBA
03/2015 - 03/2002
16LigandsIBA
04/2022 - 08/2004
16AntigensIBA
12/2021 - 07/2005
16Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2015 - 03/2002
15Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2019 - 12/2010
15Anti-Infective Agents (Microbicides)IBA
08/2006 - 08/2002
14Immunoglobulin G (IgG)IBA
02/2021 - 04/2003
13Imiquimod (Aldara)FDA LinkGeneric
01/2022 - 02/2013
13CholesterolIBA
10/2017 - 02/2002
12Interleukin-17 (Interleukin 17)IBA
11/2020 - 06/2008
12ImmunosorbentsIBA
01/2015 - 04/2003
11Messenger RNA (mRNA)IBA
02/2021 - 05/2013
11P-SelectinIBA
12/2013 - 05/2003
10Interleukin-10 (Interleukin 10)IBA
02/2021 - 08/2008
10AntibodiesIBA
02/2021 - 12/2005
9InterleukinsIBA
09/2022 - 07/2016
9C-Reactive ProteinIBA
01/2022 - 05/2006
9SteroidsIBA
12/2020 - 04/2004
9E-SelectinIBA
12/2013 - 05/2003
8anti-scl-70 autoantibodiesIBA
01/2017 - 06/2004
7Rituximab (Mabthera)FDA Link
11/2022 - 01/2014
7Biomarkers (Surrogate Marker)IBA
11/2022 - 04/2010
7Indicators and Reagents (Reagents)IBA
01/2022 - 09/2005
7Type I DNA Topoisomerases (Topoisomerase I)IBA
12/2021 - 01/2004
7Pharmaceutical PreparationsIBA
12/2020 - 12/2005
7AdiponectinIBA
01/2019 - 09/2012
7Transcription Factors (Transcription Factor)IBA
11/2018 - 12/2013
7Antigen-Antibody Complex (Immune Complex)IBA
10/2018 - 08/2004
7indium-bleomycinIBA
01/2018 - 04/2014
7AdipokinesIBA
01/2017 - 05/2013
6Chemotactic FactorsIBA
04/2022 - 07/2003
6Immunoglobulin M (IgM)IBA
06/2021 - 01/2004
6Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
11/2020 - 06/2004
6Biological ProductsIBA
09/2020 - 01/2010
6Immunoglobulin E (IgE)IBA
01/2019 - 05/2004
6SelectinsIBA
11/2011 - 05/2003
5Interleukin-4 (Interleukin 4)IBA
09/2022 - 06/2008
5Monoclonal AntibodiesIBA
04/2022 - 08/2004
5Triglycerides (Triacylglycerol)IBA
04/2022 - 04/2005
5CollagenIBA
01/2022 - 04/2003
5Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022 - 10/2011
5Immunoglobulins (Immunoglobulin)IBA
07/2021 - 01/2008
5Adrenal Cortex Hormones (Corticosteroids)IBA
12/2018 - 01/2010
5HDL CholesterolIBA
02/2013 - 02/2004
5Anti-Bacterial Agents (Antibiotics)IBA
06/2006 - 08/2002

Therapy/Procedure

40Therapeutics
09/2022 - 04/2004
5Drug Therapy (Chemotherapy)
01/2020 - 06/2008